You are here

losmapimod

Fulcrum stock slumps after muscle disorder drug fails in late-stage study

Reuters

Thu, 09/12/24 - 11:38 am

Fulcrum Therapeutics

facioscapulohumeral muscular dystrophy

clinical trials

Sanofi pays $80M to add Roche-rivaling Fulcrum drug to phase 3 rare disease pipeline

Fierce Biotech

Mon, 05/13/24 - 11:25 am

Fulcrum Therapeutics

clinical trials

Fulcrum under pressure on underwhelming losmapimod data in type of muscular dystrophy

Seeking Alpha

Tue, 08/11/20 - 11:39 am

Fulcrum Therapeutics

clinical trials

GSK punts a failed cardio drug to a biotech startup — which has a new development strategy in mind

Endpoints

Tue, 04/23/19 - 12:07 pm

Fulcrum Therapeutics

Glaxo faces another cardio R&D failure for a lead candidate

BioPharma Dive

Wed, 10/28/15 - 02:55 pm

GSK starts phase III of coronary drug test

Reuters

Thu, 06/5/14 - 12:10 pm

acute coronary syndrome